Alex Nichols
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alex Nichols
Alex Nichols is recorded as COO at enGene Therapeutics Inc. (ENGN). enGene Therapeutics Inc. reported in an 8-K filed June 15, 2026 that Alex Nichols resigned as Chief Strategy and Operations Officer, effective July 15, 2026. enGene Therapeutics Inc. reported in an 8-K filed November 9, 2023 that Alex Nichols was appointed President and Chief Operating Officer, effective November 1, 2023.
“on June 15, 2026, the Company announced that Lee Giguere, Chief Legal Officer and Secretary and Alex Nichols, Chief Strategy and Operations Officer will each depart the Company effective July 15, 2026.”
“The initial term of this Agreement shall begin on November 1, 2023 (the "Effective Date") and shall continue until the termination of the Executive's employment.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-11-01–present
-
2023-11-01–2026-07-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at enGene Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Joan Connolly CTO
- Dr. William Grossman Board Member
- Gerald Brunk Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.